.Since the issue is completely an OFS, the firm will definitely certainly not obtain any sort of proceeds and all the funds will certainly visit the marketing shareholders (Image: Shutterstock) 2 minutes reviewed Last Updated: Oct 07 2024|5:52 PM IST.Integrated diagnostic chain Suraksha Diagnostic Ltd has actually gotten Sebi's go ahead to raise funds through an initial public offering (IPO), an update with the marketplaces regulatory authority showed on Monday.The Kolkata-headquartered company's planned IPO features an Offer-for-Sale (OFS) of around 1.92 crore equity allotments through marketers as well as investor shareholders, without any new concern element, according to the Draft Diversionary Tactic Syllabus (DRHP). Click on this link to connect with our company on WhatsApp.Under the OFS, marketers-- Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma and also real estate investors-- OrbiMed Asia II Mauritius Ltd, Munna Lal Kejriwal and Santosh Kumar Kejriwal will certainly unload reveals..The company, which had filed preliminary IPO documents in July, obtained the regulatory authority's review on September 30, the improve presented.In Sebi's parlance, obtaining its own monitorings indicates the regulator's proceed to drift the general public issue.According to the receipt documents, the company is going to not obtain any proceeds and all the funds will certainly go to the offering investors as the issue is actually entirely an OFS.Explaining the main reason for going public, the firm, in its draft documents, mentioned that the directory is intended for obtaining the advantage of listing equity shares on the stock market and carrying out OFS for the offering shareholders.Given that the concern is actually totally an OFS, the company will definitely not acquire any kind of earnings and all the funds will visit the selling shareholders.Suraksha Diagnostic gives a one-stop integrated service for pathology and also radiology testing as well as clinical examination solutions to its consumers with its own extensive operational system, containing a crown jewel central recommendation research laboratory, 8 gps labs and 194 client touchpoints which include 48 analysis centers, and 146 example assortment centres (predominantly franchised), around West Bengal, Bihar, Assam and also Meghalaya as of March 31, 2024.In the course of budgetary 2024, it conducted regarding 5.98 thousand tests providing around 1.14 million patients.ICICI Securities Ltd, Nuvama Riches Management Ltd and SBI Funds Markets Ltd are the book-running lead supervisors to the concern. The capital shares are actually proposed to be detailed on BSE and also NSE.( Only the heading as well as photo of this report may possess been actually reworked by the Company Criterion staff the remainder of the web content is actually auto-generated coming from a syndicated feed.) First Posted: Oct 07 2024|5:52 PM IST.